Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. - Wikidata - awgldk - TriplyDB

Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

http://www.wikidata.org/entity/Q35116532

about

Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache Medication overuse headache: history, features, prevention and management strategies.Modelling headache and migraine and its pharmacological manipulation Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.Update on medication-overuse headache.Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache.Cortical excitability in chronic migraine.Pathophysiology of medication-overuse headache: implications from animal studies.Pathophysiology of medication overuse headache--an update.Drugs targeting nitric oxide synthase for migraine treatment.Persistent Headache and Cephalic Allodynia Attributed to Head Trauma in Children and Adolescents.Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.Migraine genetics: current findings and future lines of research.Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence Capturing the aversive state of cephalic pain preclinically.Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.Acute migraine therapy: new drugs and new approaches.Cutaneous allodynia as a predictor of migraine chronification.Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study.Macroscopic Innervation of the Dura Mater Covering the Middle Cranial Fossa in Humans Correlated to Neurovascular Headache.Side effects associated with current and prospective antimigraine pharmacotherapies.Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.Activation of dura-sensitive trigeminal neurons and increased c-Fos protein induced by morphine withdrawal in the rostral ventromedial medulla.Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.Pharmacokinetic evaluation of almotriptan for the treatment of migraines.Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.

P2860

Q33921986-5BA2AD3C-3919-4102-A24B-74A025E0251A Q34362586-3EE30568-338A-411A-899F-701B01958FB3 Q34407137-D55A144D-4C5F-47F2-9038-2BE650F739AD Q36944819-C019BFED-709F-447F-BE8C-89F2C4ECC8FC Q37019678-D1C7039C-2C2C-4371-83BA-4FCE7974D810 Q37713262-CB030E61-4CAA-4E9F-9EFF-E665C35BF034 Q37807929-195FD56B-70D7-4849-BF26-1DE87BBE288A Q37858847-49933C94-BB54-4CB9-BACD-C9FD58C2FDD5 Q37862036-438E4060-2455-490C-A5CD-4E2EDCFB2D38 Q37955113-E31BEECC-E288-422E-9B56-F9BEFD983D3B Q37955117-E51890D5-A7D0-4931-BE13-F70FE999A520 Q38151745-8CCA3BCF-6773-460E-9D64-CB5C0AEE86DE Q38211063-9F6F646F-6E6D-47F0-8762-A061331CA023 Q38843458-BE1B5F36-FE37-4E22-A667-F88919905109 Q38855312-34192280-3D2F-4135-9094-966F6BF05EF3 Q39077188-4205D175-2261-4080-8843-FF7DA8C1BBCC Q39220347-DE893CD1-30C5-4716-A824-C85EFE06943C Q39227134-731BF5DD-2C08-4B81-B6BC-812EA649693D Q39748701-F1BF9827-5BD2-4A02-9C50-E994B8A0F439 Q41300169-98F450B4-1D09-4143-8A50-1DBCB6301C1C Q41417230-06EFC418-8EF0-4DDB-A7CB-DF1AAE9DF7DD Q41642373-BAA341E6-8053-4CEC-BCF5-43042D289093 Q44142745-F24B5C74-D78F-4C9E-A358-184D8E71731A Q46534534-205305BB-F3C0-4841-9C73-15EBE59CD22B Q47186030-EE67CACA-8606-4323-A35E-A921668EF2C0 Q47309054-AD00CBF0-2166-4408-9F8E-931BB739ED19 Q48023073-C1F6F608-20B6-44E3-847D-0FEB0F51B5F0 Q48761243-2E6E0AD1-2B60-4D72-B5DE-7D875BCC7DF0 Q48932453-E9F60BEC-3C55-4905-8422-942D1DD3B242 Q50490563-541C5244-AB3C-4B8B-BABE-C4AD8CC2C33E Q53599526-0DC6E5CA-C992-4BBA-B014-E99AA2308BDF

P2860

Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

http://www.wikidata.org/entity/Q35116532

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Triptan-induced enhancement of ...... o potential migraine triggers.

@ast

Triptan-induced enhancement of ...... o potential migraine triggers.

@en

type

label

Triptan-induced enhancement of ...... o potential migraine triggers.

@ast

Triptan-induced enhancement of ...... o potential migraine triggers.

@en

prefLabel

Triptan-induced enhancement of ...... o potential migraine triggers.

@ast

Triptan-induced enhancement of ...... o potential migraine triggers.

@en

P1433

Q35116532-4437644B-B9F4-4075-B1C5-738B7CEB5767

P1476

Q35116532-506FC2A9-59D5-4323-B283-FF456506EDDF

P2093

Q35116532-3A88C16D-6CB4-40AC-9E17-EE17CDB70969

Q35116532-56E89711-3A97-438B-9AAA-44C4A2446A42

Q35116532-5A51B190-4C4C-462A-A901-2DE2778F8780

Q35116532-9F52033C-FAE6-4DFB-BE54-17A950B85E95

Q35116532-C5812861-DFD5-47DB-9969-B05D93264B16

Q35116532-D3D28043-D3AD-4767-8B0F-CE983F500E25

Q35116532-D5966862-5DA8-40B8-A8D5-4A41F7996295

Q35116532-D758EB1E-59C8-48EC-9A5A-AE37165666F2

Q35116532-D836AD96-FA89-4F6D-B280-B35F9F078A8F

Q35116532-F2202DED-EC7C-48CE-B856-72F4FDD1043F

P2860

Q35116532-018EC7F9-4B2D-4C5D-81C4-760120068EEC

Q35116532-0294BAB3-C07F-44D4-81E7-FD705EB9250A

Q35116532-03254347-AA16-4B7F-9254-C30BCF04BE83

Q35116532-087D21B9-B162-474F-A1F4-97DF212CEBB3

Q35116532-137CD92A-D2FE-451E-8D8C-92201B5CEA70

Q35116532-15DD3CA5-9B9E-43E0-8B8B-C3051C0939DF

Q35116532-161355E3-1B6B-4FC4-9CD9-6FDA9ABA550E

Q35116532-17446A13-3393-48D3-B717-553CDE7EE4D9

Q35116532-189AC328-9068-4BB2-92A0-5CF764F781EA

Q35116532-20A768DA-F9B8-4961-9259-0C4F305243F5

P304

Q35116532-9A4D790C-F4B5-4EA6-81F7-5198E36678C8

P31

Q35116532-E0A693C0-E729-4C3B-AAFC-8EE0EA589F2F

P356

Q35116532-CA0CE601-0A5A-458D-A8D9-AC2C05862C83

P407

Q35116532-36E28CAE-B2CE-4274-836F-1A974074E2BE

P433

Q35116532-1C672A37-77CC-4B82-9409-BCC75A465F4B

P478

Q35116532-95210674-9062-417C-BF90-A384CE81E2CE

P50

Q35116532-980B5350-878C-4BD8-A06D-DB8E3CDA88D7

P577

Q35116532-4BBE1E33-6D13-48CB-BC6B-81128C99F2FA

P5875

Q35116532-6CC30FFE-C2C6-4934-8F7A-FD4B4F544913

P698

Q35116532-4728ED7B-11B2-452A-B514-44846B033A0B

P921

Q35116532-0E6653BE-3913-4157-822E-02386E29053A

P932

Q35116532-403259A6-981D-4D11-9181-740B756AB757

P356

P1433

P1476

Triptan-induced enhancement of ...... o potential migraine triggers.

@en

P2093

Frank Porreca

http://www.w3.org/2001/XMLSchema#string

Gregory Dussor

http://www.w3.org/2001/XMLSchema#string

Ian D Meng

http://www.w3.org/2001/XMLSchema#string

John S Andrews

http://www.w3.org/2001/XMLSchema#string

Josephine Lai

http://www.w3.org/2001/XMLSchema#string

Juliana Chichorro

http://www.w3.org/2001/XMLSchema#string

Michael H Ossipov

http://www.w3.org/2001/XMLSchema#string

Milena De Felice

http://www.w3.org/2001/XMLSchema#string

Ruizhong Wang

http://www.w3.org/2001/XMLSchema#string

Shawn Maddaford

http://www.w3.org/2001/XMLSchema#string

P2860

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Excessive opioid use and the development of chronic migraine

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

Calcitonin gene-related peptide and its role in migraine pathophysiology

Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura

Quantitative assessment of tactile allodynia in the rat paw

Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120.

How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.

Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis.

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.

P304

2475-2488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWQ159

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 8

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45185209

http://www.w3.org/2001/XMLSchema#string

P698

20627971

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

3139937

http://www.w3.org/2001/XMLSchema#string